ArticleBlood advances2022
Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose study.
Toshko Lissitchkov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled ittrialcites it
ArticleBlood advances2022
Toshko Lissitchkov et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.